论文部分内容阅读
Ａｎｇｓｔｒｏｍ医药公司的抗血管生成药具抗癌作用 加拿大ＭｃＧｉｌｌ大学的研究人员发现，Ａｎｇｓｔｒｏｍ医药公司的抗血管生成药６能抑制接种在小鼠身上的人类乳腺癌的生长与转移。抗血管生成药６是一个短肽分子，由对肿瘤扩散和转移起重要作用的尿激酶纤溶酶原激
Angstrom Pharmaceuticals ’Antiangiogenic Drugs Have Anticancer Effects Researchers at McGill University in Canada have found that Angstrom Pharmaceuticals’ antiangiogenic drug 6 inhibits the growth and metastasis of human breast cancer in mice. Anti-angiogenic drug 6 is a short peptide molecule that plays a key role in urokinase plasminogen